Cargando…

VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma

PURPOSE: The purpose of this study was to evaluate potential prognostic factors in patients with adenoid cystic carcinoma (ACC). MATERIALS AND METHODS: A total of 68 patients who underwent curative surgery and had available tissue were enrolled in this study. Their medical records and pathologic sli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Seongyeol, Nam, Soo Jeong, Keam, Bhumsuk, Kim, Tae Min, Jeon, Yoon Kyung, Lee, Se-Hoon, Hah, J. Hun, Kwon, Tack-Kyun, Kim, Dong-Wan, Sung, Myung-Whun, Heo, Dae Seog, Bang, Yung-Jue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843710/ https://www.ncbi.nlm.nih.gov/pubmed/26194375 http://dx.doi.org/10.4143/crt.2015.093

Ejemplares similares

Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma
por: Ha, Hyerim, et al.
Publicado: (2021)

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
por: Keam, Bhumsuk, et al.
Publicado: (2011)

Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study
por: Kim, Ryul, et al.
Publicado: (2016)

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
por: Ock, Chan-Young, et al.
Publicado: (2016)

Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation
por: Ock, Chan-Young, et al.
Publicado: (2016)

Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy
por: Wee, Chan Woo, et al.
Publicado: (2015)

Adenoid Cystic Carcinoma of the Breast: A Case Series of Six Patients and Literature Review
por: Kim, Miso, et al.
Publicado: (2014)

Definitive Radiotherapy versus Postoperative Radiotherapy for Tonsil Cancer
por: Koo, Tae Ryool, et al.
Publicado: (2012)

Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?
por: Yoo, Shin Hye, et al.
Publicado: (2019)

Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations
por: Park, Sehhoon, et al.
Publicado: (2016)

Prediction of Extrathyroidal Extension Using Ultrasonography and Computed Tomography
por: Lee, Doh Young, et al.
Publicado: (2014)

A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma
por: Hanna, Glenn J., et al.
Publicado: (2023)

Optimal timing for salvage surgery after definitive radiotherapy in hypopharyngeal cancer
por: Chun, Seok-Joo, et al.
Publicado: (2018)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Clinical Manifestations of Recurrent Parotid Pleomorphic Adenoma
por: Suh, Myung-Whan, et al.
Publicado: (2009)

Correlationship between Ki67, VEGF, and p53 and Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
por: Zhang, Xia, et al.
Publicado: (2021)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Male Breast Adenoid Cystic Carcinoma
por: Yoo, Seung Jin, et al.
Publicado: (2013)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Comprehensive Cytomorphologic Analysis of Pulmonary Adenoid Cystic Carcinoma: Comparison to Small Cell Carcinoma and Non-pulmonary Adenoid Cystic Carcinoma
por: Kim, Seokhwi, et al.
Publicado: (2015)

Correlation and significance of COX-2, Ki67, VEGF and other immune indexes with the growth of malignant pulmonary nodules
por: Guo, Haoxin, et al.
Publicado: (2022)

Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure
por: Lim, Yu Jin, et al.
Publicado: (2015)

Molecular subtyping of ependymoma and prognostic impact of Ki-67
por: Lim, Ka Young, et al.
Publicado: (2021)

A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma
por: Kim, Dong-Wan, et al.
Publicado: (2014)

Adenoid cystic carcinoma of palate
por: Mehta, Dhaval N., et al.
Publicado: (2013)

Dedifferentiation in adenoid cystic carcinoma
por: Bavle, Radhika M, et al.
Publicado: (2013)

Adenoid cystic carcinoma of the breast
por: Thomas, Devon N, et al.
Publicado: (2019)

Adenoid Cystic Carcinoma of Mandible
por: Santos, Thiago de Santana, et al.
Publicado: (2015)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

Customized Tracheostomy Cannula as a Therapeutic Adjunct in Tracheal Stenosis
por: Lee, Doh Young, et al.
Publicado: (2013)

A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors
por: Hanna, Glenn J., et al.
Publicado: (2023)

Clinical Significance of Ki-67 Labeling Index in Pituitary Macroadenoma
por: Paek, Kyung-Il, et al.
Publicado: (2005)

Prognostic Value of Immunohistochemical Staining of p53, bcl-2, and Ki-67 in Small Cell Lung Cancer
por: Paik, Kwang Hyun, et al.
Publicado: (2006)

The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer
por: Yoo, Shin Hye, et al.
Publicado: (2018)

Generalization and representativeness of phase III immune checkpoint blockade trials in non‐small cell lung cancer
por: Yoo, Shin Hye, et al.
Publicado: (2018)

Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment
por: Oh, So Yeon, et al.
Publicado: (2021)

CAIX在NSCLC中的表达及其与VEGF和Ki67表达的相关性
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vm7n5g973h6m5lokt4a34d29ia